Andrew McKibben
SVP of Strategic Finance and Investor Relations
Replay available
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) Q2 2026 earnings conference call, held 2026-08-05. Replay captured from the company's public earnings webcast.

SVP of Strategic Finance and Investor Relations
Chief Executive Officer
President and Chief Operating Officer
Chief Financial Officer
Analyst, Raymond James
Analyst, Evercore ISI
Analyst, Wolfe Research
Analyst, Stifel
Watch the replay and follow the connected company analysis, news, and investor updates for Mirum Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.052 Good afternoon, and welcome to Merum Pharmaceuticals' second quarter 00:00:05.052 -- 00:00:10.093 2026 earnings conference call. My name is Alexandra, and I will be your operator 00:00:10.093 -- 00:00:15.094 today. All lines are currently in a listen-only mode, and there 00:00:15.094 -- 00:00:19.854 will be an opportunity for Q&A after management's prepared remarks. 00:00:19.854 -- 00:00:24.855 I would now like to hand the conference over to Andrew McKibben, SVP of 00:00:24.855 -- 00:00:30.576 Strategic Finance and Investor Relations. Please go ahead. 00:00:31.152 -- 00:00:33.874 Thank you, Alexandra, and good afternoon, everyone. 00:00:33.874 -- 00:00:38.397 I'd like to welcome you to Miriam Pharmaceuticals' second quarter 2026 conference call. 00:00:38.397 -- 00:00:42.799 I'm joined today by our Chief Executive Officer, Chris Peetz, our President and Chief 00:00:42.799 -- 00:00:47.082 Operating Officer, Peter Radovich, and Eric Bjerkholt, our Chief Financial Officer. 00:00:47.082 -- 00:00:50.404 Lara Longpre, our Chief Development Officer, will be joining us for the Q&A portion of 00:00:50.404 -- 00:00:54.346 the call. Joanne Quan, our Chief Medical Officer, could not be with us today due to a 00:00:54.346 -- 00:00:58.229 family matter. Earlier today, Miriam issued a press release announcing the company's 00:00:58.229 -- 00:01:02.847 results for the second quarter of 2026. Copies of the press release and our SEC filings 00:01:02.847 -- 00:01:05.829 are available on the Investors section of our website. 00:01:05.829 -- 00:01:08.931 Before we start, I'd like to remind you that during the course of this conference call, 00:01:08.931 -- 00:01:13.274 we will be making certain forward-looking statements based on management's current ex...